For people with severe allergies, having an EpiPen can mean the difference between life and death. Because there’s no generic alternative, EpiPen manufacturer Mylan just keeps jacking up the price and ripping off patients. They also seem to have ripped off the government. Today, a probe by the Department of Health and Human Services concluded that the company actually stiffed taxpayers for three times more than was previously believed.
Back in October, Mylan agreed to pay the US government $465 million without admitting any wrongdoing. It was the end of a long saga that showed what a vile company Mylan is and it was quickly rewarded with a bounce in its stock price. Senator Chuck Grassley released the findings of the HHS report today and he’s indicating that the final price that Mylan will need to pay may not be settled yet. “Mylan and the Obama Administration reportedly were close to settling the overpayment for much less than $1.27 billion,” Grassley writes in the statement. “Taxpayers have a right to know what happened here and to be repaid whatever they are owed.”
No comments:
Post a Comment